Science Advances

This PDF file includes:

• fig. S1. Characterization of BC samples used in genome-wide analyses.
• fig. S2. TET1 and immune markers in non-BLBC BC subtypes.
• fig. S3. TET1 expression and immunity in BLBC.
• fig. S4. Non-BLBC subtypes do not show a strong correlation between TET1 expression and immunity.
• fig. S5. Immune pathways modulate TET1 expression in BC.
• fig. S6. Activation of NF-κB in BC cells.
• fig. S7. NF-κB and TET1 in additional BC cell lines.
• fig. S8. Immunity and TET2 and TET3 in BLBC.
• fig. S9. TET1 promoter and streptavidin-agarose pulldown probes.
• fig. S10. TET1 and immunity in thyroid, melanoma, and lung cancers.
• fig. S11. TET1 and immunity in additional cancer types.
• fig. S12. TET1 expression and NF-κB in additional cancer types.
• Legend for table S1
• table S2. Genes negatively correlating with TET1 in BLBC (TCGA)—Top 5 of gene ontology categories.
• table S3. Genes positively correlating with TET1 in BLBC (TCGA)—Top 5 of gene ontology categories.
• table S4. List of primers.

Download PDF

Other Supplementary Material for this manuscript includes the following:

• table S1. List of dhmRs in BLBC (Excel file).